23. Prion disease Clinical trials / Disease details

Clinical trials : 4 / Drugs : 5 - (DrugBank : 2) / Drug target gene : 0 - Drug target pathway : 0

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00183092 (ClinicalTrials.gov)	April 2005	14/9/2005	CJD (Creutzfeldt-Jakob Disease) Quinacrine Study	Novel Therapeutics For Prion Diseases: A Randomized, Double-blinded, Placebo-controlled Study of the Efficacy of Quinacrine in the Treatment of Sporadic Creutzfeldt-Jakob Disease	Creutzfeldt-Jakob Disease	Drug: Quinacrine;Drug: Placebo	University of California, San Francisco	National Institute on Aging (NIA)	Completed	18 Years	N/A	All	69	Phase 2	United States
2	NCT00104663 (ClinicalTrials.gov)	June 2004	3/3/2005	PRION-1: Quinacrine for Human Prion Disease	PRION-1: Quinacrine for Human Prion Disease. A Partially Randomized Patient Preference Trial to Evaluate the Activity and Safety of Quinacrine in Human Prion Disease	Prion Disease	Drug: Quinacrine	Medical Research Council	NULL	Completed	12 Years	N/A	Both	160	N/A	United Kingdom